Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a limited duration of treatment (two weeks
of low molecular weight treatment) is a safe and effective treatment for distal deep vein
thrombosis of the lower limb.
Phase:
Phase 4
Details
Lead Sponsor:
Monash Medical Centre
Collaborators:
Auckland City Hospital Christchurch Hospital, NZ Eastern Health, Victoria Middlemore Hospital, New Zealand North Shore Hospital, New Zealand Prince of Wales Hospital, Sydney Royal Adelaide Hospital, Adelaide Southern Health, Victoria